Mallinckrodt Pays $35M to Settle Opioid Drug Probe

Jul 12, 2017

Reuters

Mallinckrodt Plc, which makes generic opioid painkiller oxycodone, agreed to pay $35 million to settle allegations that it did not report suspicious drug orders, according to a Reuters report. However, Mallinckrodt did not admit any wrongdoing.

The deal was said to be a record settlement resulting from a drug manufacturer not notifying the U.S. Drug Enforcement Administration of suspicious drug orders such as oxycodone, the Justice Department said.

U.S. Attorney General Jeff Sessions said the settlement will send a message to other drugmakers that the Justice Department will hold them accountable for their actions, the story said.

Read the full article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments